Clinical Trials
5 trialsNCT05853458 2026-04-30
HU-F-AIM
Novartis
Phase 4 Terminated
NCT02228382 2021-12-30
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
Pfizer
Phase 4 Terminated
NCT02204722 2018-06-15
IDEAL
Dong-A ST Co., Ltd.
Phase 4 Terminated
NCT02086487 2017-03-07
NISRI
King Abdullah International Medical Research Center
Phase 4 Terminated
NCT00461929 2009-02-13
GIST
University Health Network, Toronto
Phase 4 Terminated